These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11231307)

  • 1. Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin.
    Rømer J; Pyke C; Lund LR; Ralfkiaer E; Danø K
    J Invest Dermatol; 2001 Mar; 116(3):353-8. PubMed ID: 11231307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds.
    Rømer J; Lund LR; Eriksen J; Pyke C; Kristensen P; Danø K
    J Invest Dermatol; 1994 Apr; 102(4):519-22. PubMed ID: 8151132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.
    Shiomi H; Eguchi Y; Tani T; Kodama M; Hattori T
    Am J Pathol; 2000 Feb; 156(2):567-75. PubMed ID: 10666386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
    Marschall C; Lengyel E; Nobutoh T; Braungart E; Douwes K; Simon A; Magdolen V; Reuning U; Degitz K
    J Invest Dermatol; 1999 Jul; 113(1):69-76. PubMed ID: 10417621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
    Foca C; Moses EK; Quinn MA; Rice GE
    Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
    Braungart E; Magdolen V; Degitz K
    J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion.
    Rømer J; Pyke C; Lund LR; Eriksen J; Kristensen P; Rønne E; Høyer-Hansen G; Danø K; Brünner N
    Int J Cancer; 1994 May; 57(4):553-60. PubMed ID: 8181859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype.
    Swiercz R; Wolfe JD; Zaher A; Jankun J
    Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas.
    Pyke C; Salo S; Ralfkiaer E; Rømer J; Danø K; Tryggvason K
    Cancer Res; 1995 Sep; 55(18):4132-9. PubMed ID: 7664291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization.
    Morita S; Sato A; Hayakawa H; Ihara H; Urano T; Takada Y; Takada A
    Int J Cancer; 1998 Oct; 78(3):286-92. PubMed ID: 9766559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of urokinase plasminogen activator components in basal cell carcinoma of the skin.
    Maguire T; Chin D; Soutar D; Duffy MJ
    Int J Cancer; 2000 Feb; 85(4):457-9. PubMed ID: 10699914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
    Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma.
    Wang J; Guo F; Wei H; Dong J; Wu J
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):515-9. PubMed ID: 16356605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.
    Lund LR; Eriksen J; Ralfkiaer E; Rømer J
    J Invest Dermatol; 1996 Apr; 106(4):622-30. PubMed ID: 8617995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity.
    Clayman G; Wang SW; Nicolson GL; el-Naggar A; Mazar A; Henkin J; Blasi F; Goepfert H; Boyd DD
    Int J Cancer; 1993 Apr; 54(1):73-80. PubMed ID: 8386710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.
    Bolon I; Gouyer V; Devouassoux M; Vandenbunder B; Wernert N; Moro D; Brambilla C; Brambilla E
    Am J Pathol; 1995 Nov; 147(5):1298-310. PubMed ID: 7485393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
    Durko M; Brodt P
    Biochem Biophys Res Commun; 1998 Jun; 247(2):342-8. PubMed ID: 9642128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.